Elizabeth Yeu Lin, Director at Tarsus Pharmaceuticals, Inc. (TARS), bought 36,800 shares at $16.03 ($593K) on 2022-09-14, disclosed to the SEC on 2022-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.03 | 12,040 | $193K | 32.5% |
| 2 | $16.03 | 12,040 | $193K | 32.5% |
| 3 | $16.29 | 6,360 | $104K | 17.5% |
| 4 | $16.29 | 6,360 | $104K | 17.5% |
| Total | $16.12 avg | 36,800 | $593K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $78K | — | Filing → |
| TARS | SELL | 2025-12-17 | $165K | — | Filing → |
| TARS | SELL | 2025-06-17 | $41K | — | Filing → |